PTX

2.56%

3.8¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-406

First 406 Last

Share
Profile

Follow
dalts66

4,317 Posts.

2019

09/08/22

11:55

Post #: 63006595
Share

Originally posted by Shellbell: ↑

"Another round of explanations and new strategies in the clinic [from Amgen] isn’t likely going to be well received by anyone. But don’t expect anyone to lose interest now. Mastering KRAS has game-changing potential in oncology — for whoever comes out on top."

Thanks for keeping us uptodate with what's with KRAS trials, Dalts. Interesting that Lumakras achieves positive outcomes as a monotherapy but disappointed in combo with the PD1 checkpoint inhibitor. The concern is that perhaps KRAS targeted therapies may not be as successful as had hoped in combo with immunotherapy drugs. Attention will now turn to Mirati with their more promising combo results to date - in the hope that Amgen's results aren't indicative of a class response.

Certainly an interesting space. It was brought up in the recent panel discussion with Dan Shelly who presented for PTX, that the FDA is focusing in on targeted therapies. The outcomes to our PTX100 expansion trial is going to have much attention on it. Its safety as a monotherapy has already been established to a large degree... so, now its all about the efficacy data (and, to a lesser degree, any other interesting indications it may throw up as a target against KRAS).a

Can't not sign off without mentioning the sad loss of Olivia Newton-John. Such a wonderful lady who battled cancer for decades, did so much to help others and touched people across the world with her generosity, determination and down-to-earth nature. Her legacy will live on with the Olivia Newton-John Cancer Research and Wellness Institute in Melbourne. Sad day.

Expand

KRAS has lots of potential. Only early days but showing so much promise.
The PTX much broader spectrum makes PTX100 look exciting. The expansion trial will be important.

PTX Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

RCE

Recce's R327 found effective against E.coli during clinical trial

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 1 more message in this thread...

First 406 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 3.8¢		Change -0.001(2.56%)		Mkt cap ! $30.60M

Open	High	Low	Value	Volume
3.9¢	3.9¢	3.8¢	$47.91K	1.256M

Buyers (Bids)

No.	Vol.	Price($)
11	881755	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	150000	2

View Market Depth

No.	Vol.	Price($)
11	881755	0.038
5	393000	0.037
8	688946	0.036
7	500304	0.035
2	140000	0.034

Price($)	Vol.	No.
0.039	150000	2
0.040	200000	2
0.041	66157	1
0.042	180000	2
0.043	300000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PTX (ASX) Chart

Ann: PTX-100 trial advances following successful Phase 1b, page-406

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PTX-100 trial advances following successful Phase 1b, page-406

Top Stories

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News